Neurocrine Biosciences, Inc. · San Diego, CA United States (NASDAQ: NBIX)
| 12780 El Camino Real | Phone: 858-617-7600 |
| San Diego, CA | Fax: 858-617-7601 |
| 92130 | |
| United States | 
Map This Company |
Neurocrine Biosciences, Inc. Rankings
More Companies in These Related Industries: Medicinals & Botanicals Mfg, Pharmaceutical Preparation MfgCompany Description
For Neurocrine Biosciences, drug development is all about body chemistry. The development-stage biotech develops treatments for neurological and endocrine hormone-related diseases, such as insomnia, depression, and menstrual pain. Lead drug candidate Elagolix is designed to treat endometriosis which causes pain and irregular menstrual bleeding in women. Neurocrine Biosciences works in additional therapeutic areas including anxiety, diabetes, and movement disorders. The company has about a dozen drug candidates in various stages of research and clinical development, through both internal programs and collaborative agreements with partnering drug firms.
Neurocrine Biosciences, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: NBIX Single Location |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 71 |
Executives
25 executives listed for Neurocrine Biosciences, Inc.'s San Diego, CA location.
| Chairman | Joseph Mollica | |
|---|---|---|
| President, CEO, and Director | Kevin Gorman | |
| VP and CFO | Timothy Coughlin |